ImmunoBiology Ltd Company
ImmBio is developing next-generation vaccines targeting a number of serious infectious diseases, based on its proprietary technologies.
Industry:
PharmTech
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Employees Number:
51-100
Estimated Revenue:
$10M to $50M
Register and Claim Ownership